broad_id
string | depmap_id
string | ccle_name
string | screen_id
string | upper_limit
int64 | lower_limit
float64 | slope
float64 | r2
float64 | auc
float64 | ec50
float64 | ic50
float64 | name
string | moa
string | target
string | disease.area
string | indication
string | smiles
string | phase
string | passed_str_profiling
bool | row_name
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRD-K71847383-001-12-5 | ACH-000288 | BT549_BREAST | HTS002 | 1 | 1.810211 | 0.111243 | -0.003031 | 1.302289 | 9.260129 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000288 |
BRD-K71847383-001-12-5 | ACH-000415 | BICR6_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 1.409581 | 0.120752 | -0.061802 | 1.169222 | 1.550463 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000415 |
BRD-K71847383-001-12-5 | ACH-000228 | BICR31_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 1.982005 | -0.164109 | 0.131114 | 1.369119 | 0.003036 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000228 |
BRD-K71847383-001-12-5 | ACH-000977 | LNCAPCLONEFGC_PROSTATE | HTS002 | 1 | 1.176368 | 5.44413 | -0.142784 | 1.088256 | 0.077814 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000977 |
BRD-K71847383-001-12-5 | ACH-000397 | TEN_ENDOMETRIUM | HTS002 | 1 | 2.26404 | -0.082945 | 0.010249 | 1.492828 | 0.000329 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000397 |
BRD-K71847383-001-12-5 | ACH-000565 | RCM1_LARGE_INTESTINE | HTS002 | 1 | 1.590267 | 0.109949 | -0.042492 | 1.302732 | 0.048366 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000565 |
BRD-K71847383-001-12-5 | ACH-000209 | SNU1079_BILIARY_TRACT | HTS002 | 1 | 1.555816 | 0.12506 | -0.095405 | 1.29347 | 0.031018 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000209 |
BRD-K71847383-001-12-5 | ACH-000927 | BT474_BREAST | HTS002 | 1 | 1.595816 | 0.117463 | 0.035402 | 1.243364 | 1.988602 | null | cytarabine | ribonucleotide reductase inhibitor | POLA1, POLB, POLD1, POLE | hematologic malignancy | acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL) | Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1, Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 | Launched | true | ACH-000927 |
BRD-A98990573-003-01-3 | ACH-000879 | MFE296_ENDOMETRIUM | HTS002 | 1 | 2.406651 | -0.073609 | -0.123828 | 1.718502 | 0.141302 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000879 |
BRD-A98990573-003-01-3 | ACH-000320 | PSN1_PANCREAS | HTS002 | 1 | 2.153169 | 0.01822 | -0.015702 | 1.565786 | 0.611409 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000320 |
BRD-A98990573-003-01-3 | ACH-001145 | OC316_OVARY | HTS002 | 1 | 1.930698 | -0.128307 | 0.013193 | 1.525007 | 0.621301 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-001145 |
BRD-A98990573-003-01-3 | ACH-000873 | KYSE270_OESOPHAGUS | HTS002 | 1 | 1.663819 | 0.09446 | 0.017444 | 1.333858 | 0.068841 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000873 |
BRD-A98990573-003-01-3 | ACH-000855 | KYSE150_OESOPHAGUS | HTS002 | 1 | 2.443731 | 0.035814 | -0.07384 | 1.461459 | 119,125,404.206814 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000855 |
BRD-A98990573-003-01-3 | ACH-000913 | ESS1_ENDOMETRIUM | HTS002 | 1 | 1.986984 | 0.276565 | 0.206415 | 1.455895 | 0.147025 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000913 |
BRD-A98990573-003-01-3 | ACH-000558 | A172_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 2.393393 | -0.198751 | -0.162024 | 1.581816 | 0.012899 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000558 |
BRD-A98990573-003-01-3 | ACH-000593 | BC3C_URINARY_TRACT | HTS002 | 1 | 2.131649 | 0.0142 | 0.017346 | 1.544465 | 15.994651 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000593 |
BRD-A98990573-003-01-3 | ACH-000488 | TE11_OESOPHAGUS | HTS002 | 1 | 1.403471 | -0.146593 | 0.056054 | 1.249404 | 2.389566 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000488 |
BRD-A98990573-003-01-3 | ACH-000832 | CAL27_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 1.806094 | -0.136659 | -0.006901 | 1.462856 | 0.753831 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000832 |
BRD-A98990573-003-01-3 | ACH-000781 | NCIH2023_LUNG | HTS002 | 1 | 2.116241 | 0.013514 | -0.043877 | 1.562774 | 0.022735 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000781 |
BRD-A98990573-003-01-3 | ACH-000833 | RH30_SOFT_TISSUE | HTS002 | 1 | 1.704559 | -0.009088 | -0.044286 | 1.355226 | 0.492545 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000833 |
BRD-A98990573-003-01-3 | ACH-000137 | 8MGBA_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.912906 | 0.080341 | -0.114723 | 1.510014 | 0.004002 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000137 |
BRD-A98990573-003-01-3 | ACH-000632 | HS944T_SKIN | HTS002 | 1 | 1.808378 | -0.002097 | -0.205969 | 1.405029 | 0.567232 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000632 |
BRD-A98990573-003-01-3 | ACH-000630 | YD8_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 1.659657 | 0.212536 | -0.070869 | 1.347965 | 0.044491 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000630 |
BRD-A98990573-003-01-3 | ACH-000266 | SNU213_PANCREAS | HTS002 | 1 | 2.197751 | -0.07709 | -0.101426 | 1.680144 | 2.812235 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000266 |
BRD-A98990573-003-01-3 | ACH-000047 | GCIY_STOMACH | HTS002 | 1 | 1.169463 | -0.063424 | -0.122913 | 1.0977 | 10.520899 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000047 |
BRD-A98990573-003-01-3 | ACH-000273 | SF539_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.781141 | -0.17458 | -0.010169 | 1.428111 | 0.251615 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000273 |
BRD-A98990573-003-01-3 | ACH-000682 | SNU1066_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 0.906513 | 0.253387 | -0.001659 | 0.940251 | 0.006255 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000682 |
BRD-A98990573-003-01-3 | ACH-000359 | MG63_BONE | HTS002 | 1 | 0.678547 | 0.290458 | -0.106625 | 0.753177 | 0.000707 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000359 |
BRD-A98990573-003-01-3 | ACH-000846 | FADU_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 0.687044 | 0.113647 | 0.01733 | 0.945489 | 92,317.295283 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000846 |
BRD-A98990573-003-01-3 | ACH-000804 | NB1_AUTONOMIC_GANGLIA | HTS002 | 1 | 1.03215 | -0.193507 | -0.043366 | 1.018095 | 0.31676 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000804 |
BRD-A98990573-003-01-3 | ACH-000609 | SF126_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 0.722635 | -0.381214 | -0.036432 | 0.8183 | 0.651099 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000609 |
BRD-A98990573-003-01-3 | ACH-000974 | SNGM_ENDOMETRIUM | HTS002 | 1 | 1.995466 | -0.168702 | -0.009664 | 1.500396 | 0.083533 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000974 |
BRD-A98990573-003-01-3 | ACH-000987 | MEWO_SKIN | HTS002 | 1 | 1.650375 | 0.375233 | 0.301196 | 1.303564 | 0.122256 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000987 |
BRD-A98990573-003-01-3 | ACH-000787 | LXF289_LUNG | HTS002 | 1 | 1.532402 | 0.858926 | 0.228983 | 1.255558 | 0.095433 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000787 |
BRD-A98990573-003-01-3 | ACH-000561 | TT_OESOPHAGUS | HTS002 | 1 | 1.274219 | -0.017798 | 0.004438 | 1.158504 | 3,764,418.111465 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000561 |
BRD-A98990573-003-01-3 | ACH-000212 | CAL120_BREAST | HTS002 | 1 | 1.842452 | 0.128951 | 0.033742 | 1.405999 | 0.139407 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000212 |
BRD-A98990573-003-01-3 | ACH-000753 | JMSU1_URINARY_TRACT | HTS002 | 1 | 1.49449 | -0.236912 | 0.022282 | 1.270752 | 0.190536 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000753 |
BRD-A98990573-003-01-3 | ACH-000305 | ECGI10_OESOPHAGUS | HTS002 | 1 | 1.61547 | -0.052329 | -0.029299 | 1.358002 | 43.970646 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000305 |
BRD-A98990573-003-01-3 | ACH-000138 | CFPAC1_PANCREAS | HTS002 | 1 | 1.753365 | 0.257979 | 0.130517 | 1.380023 | 0.072298 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000138 |
BRD-A98990573-003-01-3 | ACH-000250 | KMRC20_KIDNEY | HTS002 | 1 | 1.494624 | 0.395246 | 0.190654 | 1.209002 | 0.215924 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000250 |
BRD-A98990573-003-01-3 | ACH-000856 | CAL51_BREAST | HTS002 | 1 | 1.735025 | -0.228678 | 0.10814 | 1.285053 | 0.008714 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000856 |
BRD-A98990573-003-01-3 | ACH-000046 | ACHN_KIDNEY | HTS002 | 1 | 2.014146 | 0.0271 | -0.020242 | 1.465787 | 32.507875 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000046 |
BRD-A98990573-003-01-3 | ACH-000878 | HCC15_LUNG | HTS002 | 1 | 1.964366 | 0.135892 | 0.020902 | 1.235052 | 425.682928 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000878 |
BRD-A98990573-003-01-3 | ACH-000766 | NCIH1648_LUNG | HTS002 | 1 | 1.552756 | 0.044905 | 0.023289 | 1.263833 | 0.595469 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000766 |
BRD-A98990573-003-01-3 | ACH-000014 | HS294T_SKIN | HTS002 | 1 | 1.866487 | -0.441467 | 0.082457 | 1.491065 | 0.177963 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000014 |
BRD-A98990573-003-01-3 | ACH-000701 | RMUGS_OVARY | HTS002 | 1 | 1.93928 | -0.108778 | 0.062088 | 1.4956 | 0.221216 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000701 |
BRD-A98990573-003-01-3 | ACH-000884 | MDAMB435S_SKIN | HTS002 | 1 | 1.561581 | -0.062436 | -0.00177 | 1.511362 | 1,325,035,067,871,792 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000884 |
BRD-A98990573-003-01-3 | ACH-000037 | S117_SOFT_TISSUE | HTS002 | 1 | 2.610757 | -0.322145 | 0.057094 | 1.353067 | 0.000771 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000037 |
BRD-A98990573-003-01-3 | ACH-000502 | TCCPAN2_PANCREAS | HTS002 | 1 | 1.791147 | 0.046662 | -0.052582 | 1.445164 | 0.000344 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000502 |
BRD-A98990573-003-01-3 | ACH-000886 | NCIH2009_LUNG | HTS002 | 1 | 1.824982 | -0.040267 | 0.016273 | 1.40362 | 0.02675 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000886 |
BRD-A98990573-003-01-3 | ACH-000035 | NCIH1650_LUNG | HTS002 | 1 | 1.275007 | 0.014939 | -0.127125 | 1.13901 | 0.017995 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000035 |
BRD-A98990573-003-01-3 | ACH-000661 | WM1799_SKIN | HTS002 | 1 | 1.373218 | 0.176351 | 0.033827 | 1.191805 | 0.055892 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000661 |
BRD-A98990573-003-01-3 | ACH-000391 | MHHES1_BONE | HTS002 | 1 | 1.321053 | -0.094279 | -0.007156 | 1.150176 | 0.019392 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000391 |
BRD-A98990573-003-01-3 | ACH-000843 | HARA_LUNG | HTS002 | 1 | 1.976587 | -0.10598 | 0.080794 | 1.457676 | 0.023278 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000843 |
BRD-A98990573-003-01-3 | ACH-000711 | JIMT1_BREAST | HTS002 | 1 | 1.948984 | 0.184036 | 0.071032 | 1.52785 | 0.021135 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000711 |
BRD-A98990573-003-01-3 | ACH-000232 | U251MG_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.542617 | 0.219233 | 0.156442 | 1.261488 | 0.112082 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000232 |
BRD-A98990573-003-01-3 | ACH-000060 | PANC1005_PANCREAS | HTS002 | 1 | 1.801116 | 0.105156 | -0.010876 | 1.297048 | 13.271048 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000060 |
BRD-A98990573-003-01-3 | ACH-000322 | HT144_SKIN | HTS002 | 1 | 2.744352 | 0.163127 | 0.199069 | 1.879861 | 0.069734 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000322 |
BRD-A98990573-003-01-3 | ACH-000736 | SNU601_STOMACH | HTS002 | 1 | 1.354943 | -0.272767 | -0.153729 | 1.097497 | 0.001394 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000736 |
BRD-A98990573-003-01-3 | ACH-000809 | KYSE410_OESOPHAGUS | HTS002 | 1 | 1.745682 | 0.225432 | 0.22769 | 1.36529 | 0.09516 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000809 |
BRD-A98990573-003-01-3 | ACH-000747 | NCIH1703_LUNG | HTS002 | 1 | 1.930434 | 8.051284 | 0.358434 | 1.331938 | 0.313671 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000747 |
BRD-A98990573-003-01-3 | ACH-000364 | U2OS_BONE | HTS002 | 1 | 1.623598 | -0.010964 | -0.091907 | 1.340628 | 1,739,143.771505 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000364 |
BRD-A98990573-003-01-3 | ACH-000679 | OE19_OESOPHAGUS | HTS002 | 1 | 1.981374 | 0.064406 | -0.099249 | 1.496815 | 0.052841 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000679 |
BRD-A98990573-003-01-3 | ACH-000985 | LS411N_LARGE_INTESTINE | HTS002 | 1 | 0.880762 | 1.193111 | -0.100253 | 0.951954 | 0.2018 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000985 |
BRD-A98990573-003-01-3 | ACH-000441 | SH4_SKIN | HTS002 | 1 | 1.660765 | -1.079061 | 0.253114 | 1.40478 | 0.236411 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000441 |
BRD-A98990573-003-01-3 | ACH-001113 | LC1SQSF_LUNG | HTS002 | 1 | 1.671028 | -0.623007 | 0.292925 | 1.414209 | 0.277152 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-001113 |
BRD-A98990573-003-01-3 | ACH-000620 | JHH1_LIVER | HTS002 | 1 | 6.052251 | -1.201168 | 0.02801 | 1.085837 | 0.000172 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000620 |
BRD-A98990573-003-01-3 | ACH-000853 | NCIH661_LUNG | HTS002 | 1 | 1.797602 | 0.127079 | 0.052302 | 1.374245 | 0.212531 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000853 |
BRD-A98990573-003-01-3 | ACH-000102 | GMS10_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.341286 | 0.008135 | -0.015857 | 1.171228 | 0.033644 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000102 |
BRD-A98990573-003-01-3 | ACH-000648 | NCIH28_PLEURA | HTS002 | 1 | 2.670765 | 0.188381 | 0.080214 | 1.576709 | 2.930078 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000648 |
BRD-A98990573-003-01-3 | ACH-001321 | TT_THYROID | HTS002 | 1 | 1.600621 | 0.319511 | 0.229367 | 1.325862 | 0.04134 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-001321 |
BRD-A98990573-003-01-3 | ACH-000279 | EWS502_BONE | HTS002 | 1 | 1.392272 | -0.116253 | -0.144175 | 1.318358 | 29,553.560728 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000279 |
BRD-A98990573-003-01-3 | ACH-000172 | TM87_SOFT_TISSUE | HTS002 | 1 | 1.191382 | 0.018894 | -0.123475 | 1.095645 | 0.082241 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000172 |
BRD-A98990573-003-01-3 | ACH-001128 | MON_SOFT_TISSUE | HTS002 | 1 | 2.837286 | 1.31773 | 0.351164 | 2.530067 | 0.002812 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-001128 |
BRD-A98990573-003-01-3 | ACH-000437 | SW1088_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 2.464921 | -0.161799 | 0.021702 | 1.483223 | 0.00079 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000437 |
BRD-A98990573-003-01-3 | ACH-000207 | DETROIT562_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 2.28056 | -0.229442 | 0.28321 | 1.603477 | 0.044971 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000207 |
BRD-A98990573-003-01-3 | ACH-000260 | SKNAS_AUTONOMIC_GANGLIA | HTS002 | 1 | 1.546904 | -0.151411 | -0.033138 | 1.293755 | 0.218017 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000260 |
BRD-A98990573-003-01-3 | ACH-000019 | MCF7_BREAST | HTS002 | 1 | 1.46547 | -0.100758 | -0.017226 | 1.302785 | 41.859975 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000019 |
BRD-A98990573-003-01-3 | ACH-000582 | COLO741_SKIN | HTS002 | 1 | 1.448067 | -0.27547 | -0.096245 | 1.379457 | 79.715214 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000582 |
BRD-A98990573-003-01-3 | ACH-000990 | HEC108_ENDOMETRIUM | HTS002 | 1 | 1.570831 | -0.088779 | -0.037785 | 1.476341 | 8,069,214.118125 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000990 |
BRD-A98990573-003-01-3 | ACH-000592 | TM31_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.369895 | 0.257976 | -0.091276 | 1.250242 | 0.003161 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000592 |
BRD-A98990573-003-01-3 | ACH-000368 | SNU1105_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 1.494473 | -0.146671 | -0.066263 | 1.342403 | 24.62497 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000368 |
BRD-A98990573-003-01-3 | ACH-000517 | SNU410_PANCREAS | HTS002 | 1 | 2.405004 | -0.306842 | -0.271216 | 1.315484 | 0.00073 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000517 |
BRD-A98990573-003-01-3 | ACH-000374 | HCC1143_BREAST | HTS002 | 1 | 1.971707 | -0.160977 | 0.131079 | 1.41006 | 0.010041 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000374 |
BRD-A98990573-003-01-3 | ACH-000527 | OVISE_OVARY | HTS002 | 1 | 1.663536 | 0.24615 | -0.080177 | 1.479834 | 0.001039 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000527 |
BRD-A98990573-003-01-3 | ACH-000091 | OV56_OVARY | HTS002 | 1 | 1.298686 | -0.17482 | -0.14306 | 1.177357 | 0.778295 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000091 |
BRD-A98990573-003-01-3 | ACH-000759 | MDAMB175VII_BREAST | HTS002 | 1 | 1.010161 | -0.128943 | -0.129627 | 1.006279 | 3.668881 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000759 |
BRD-A98990573-003-01-3 | ACH-000417 | PANC0813_PANCREAS | HTS002 | 1 | 1.813245 | 0.270191 | -0.044787 | 1.365034 | 0.185574 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000417 |
BRD-A98990573-003-01-3 | ACH-000308 | EFO21_OVARY | HTS002 | 1 | 1.413574 | 0.086931 | -0.024889 | 1.224231 | 0.01085 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000308 |
BRD-A98990573-003-01-3 | ACH-000991 | SNU81_LARGE_INTESTINE | HTS002 | 1 | 1.966944 | 0.040441 | -0.016903 | 1.22707 | 411,647,219,914.019 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000991 |
BRD-A98990573-003-01-3 | ACH-000948 | 2313287_STOMACH | HTS002 | 1 | 1.177057 | -0.502442 | -0.090841 | 1.118802 | 0.594219 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000948 |
BRD-A98990573-003-01-3 | ACH-000481 | NCIH2170_LUNG | HTS002 | 1 | 1.87338 | 0.008744 | -0.017357 | 1.443936 | 0.001754 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000481 |
BRD-A98990573-003-01-3 | ACH-000771 | BICR56_UPPER_AERODIGESTIVE_TRACT | HTS002 | 1 | 1.819329 | -0.09418 | 0.07333 | 1.393692 | 0.033634 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000771 |
BRD-A98990573-003-01-3 | ACH-000159 | OSRC2_KIDNEY | HTS002 | 1 | 1.262509 | 0.147054 | 0.025325 | 1.116855 | 0.372107 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000159 |
BRD-A98990573-003-01-3 | ACH-000929 | NCIH2110_LUNG | HTS002 | 1 | 3.663559 | 0.881271 | 0.148348 | 1.129812 | 21.129337 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000929 |
BRD-A98990573-003-01-3 | ACH-000118 | HUPT3_PANCREAS | HTS002 | 1 | 1.794215 | -0.358423 | 0.007789 | 1.397125 | 0.078149 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000118 |
BRD-A98990573-003-01-3 | ACH-000482 | RERFLCKJ_LUNG | HTS002 | 1 | 1.526195 | -0.088525 | -0.094492 | 1.184886 | 0.000069 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000482 |
BRD-A98990573-003-01-3 | ACH-000352 | HCC1428_BREAST | HTS002 | 1 | 1.507227 | 0.098268 | -0.075063 | 1.313161 | 0.000548 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000352 |
BRD-A98990573-003-01-3 | ACH-000235 | PANC0403_PANCREAS | HTS002 | 1 | 1.894912 | -0.030993 | -0.148693 | 1.436389 | 0.015782 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000235 |
BRD-A98990573-003-01-3 | ACH-000479 | KNS81_CENTRAL_NERVOUS_SYSTEM | HTS002 | 1 | 2.48851 | 0.050826 | -0.027301 | 1.494476 | 77,323.177171 | null | epinastine | histamine receptor antagonist | ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7 | ophthalmology | conjunctivitis | NC1=NCC2N1c1ccccc1Cc1ccccc21 | Launched | true | ACH-000479 |